![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 19/00 | |
C12N 15/62 | |||
C12N 15/867 | |||
C12N 5/10 | |||
A61K 48/00 | |||
A61P 35/00 |
(11) | Number of the document | 3170842 |
(13) | Kind of document | T |
(96) | European patent application number | 15821331.4 |
Date of filing the European patent application | 2015-07-15 | |
(97) | Date of publication of the European application | 2017-05-24 |
(45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2015/084023 |
Date | 2015-07-15 |
(87) | Number | WO 2016/008405 |
Date | 2016-01-21 |
(30) | Number | Date | Country code |
201410341504 | 2014-07-17 | CN |
(72) |
WANG, Huamao, CN
SONG, Bo, CN
CAI, Xiumei, CN
|
(73) |
CAFA THERAPEUTICS LIMITED ,
2/3 Exchange Place
I.F.S.C., Dublin D01 AE27,
IE
|
(54) | IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METHOD AND USE THEREOF |
IMMUNOLOGIC EFFECTOR CELL OF TARGETED CLD18A2, AND PREPARATION METHOD AND USE THEREOF |